Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS/STING signaling dependent on LKB1/AMPK/ULK1-mediated autophagy

被引:61
|
作者
Lu, Qing-Bo [1 ,2 ]
Ding, Yi [3 ]
Liu, Yao [4 ]
Wang, Zi-Chao [5 ]
Wu, Yu-Jie [5 ]
Niu, Kai -Ming [5 ]
Li, Ke-Xue [6 ]
Zhang, Ji -Ru [3 ]
Sun, Hai-Jian [1 ,5 ,7 ]
机构
[1] Jiangnan Univ, Wuxi Sch Med, Dept Basic Med, Wuxi 214122, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Endocrine, Wuxi 214125, Peoples R China
[3] Jiangnan Univ, Affiliated Hosp, Dept Anesthesiol, Wuxi 214125, Peoples R China
[4] Nanjing Med Univ, Affiliated Hosp 4, Dept Cardiac Ultrasound, Nanjing 210000, Jiangsu, Peoples R China
[5] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia Lane, Nanjing 210009, Peoples R China
[6] Xuzhou Med Univ, Dept Physiol, 209 Tongshan Rd, Xuzhou 221004, Peoples R China
[7] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore
基金
中国国家自然科学基金;
关键词
Diabetes; Cardiomyopathy; Metrnl; AMPK; Autophagy; STING; PHOSPHORYLATION;
D O I
10.1016/j.jare.2022.10.014
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Meteorin-like hormone (Metrnl) is ubiquitously expressed in skeletal muscle, heart, and adipose with beneficial roles in obesity, insulin resistance, and inflammation. Metrnl is found to protect against cardiac hypertrophy and doxorubicin-induced cardiotoxicity. However, its role in diabetic cardiomyopathy (DCM) is undefined.Objectives: We aimed to elucidate the potential roles of Metrnl in DCM.Methods: Gain-and loss-of-function experiments were utilized to determine the roles of Metrnl in the pathological processes of DCM. Results: We found that plasma Metrnl levels, myocardial Metrnl protein and mRNA expressions were significantly downregulated in both streptozotocin (STZ)-induced (T1D) mice and leptin receptor deficiency (db/db) (T2D) mice. Cardiac-specific overexpression (OE) of Metrnl markedly ameliorated cardiac injury and dysfunction in both T1D and T2D mice. In sharp contrast, specific deletion of Metrnl in the heart had the opposite phenotypes. In parallel, Metrnl OE ameliorated, whereas Metrnl downregulation exacerbated high glucose (HG)-elicited hypertrophy, apoptosis and oxidative damage in primary neonatal rat cardiomyocytes. Antibody-induced blockade of Metrnl eliminated the effects of benefits of Metrnl in vitro and in vivo. Mechanistically, Metrnl activated the autophagy pathway and inhibited the cGAS/ STING signaling in a LKB1/AMPK/ULK1-dependent mechanism in cardiomyocytes. Besides, Metrnlinduced ULK1 phosphorylation facilitated the dephosphorylation and mitochondrial translocation of STING where it interacted with tumor necrosis factor receptor-associated factor 2 (TRAF2), a scaffold protein and E3 ubiquitin ligase that was responsible for ubiquitination and degradation of STING, rendering cardiomyocytes sensitive to autophagy activation.Conclusion: Thus, Metrnl may be an attractive therapeutic target or regimen for treating DCM.(c) 2023 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:161 / 179
页数:19
相关论文
共 50 条
  • [21] PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy
    Zeng, Jin
    Liu, Wei
    Fan, Yi-Zeng
    He, Da-Lin
    Li, Lei
    THERANOSTICS, 2018, 8 (01): : 109 - 123
  • [22] Hypoxia induction of Proline oxidase is independent of HIF but dependent on the LKB1/AMPK signaling pathway
    Liu, Wei
    Zabirnyk, Olga
    Liu, Yongmin
    Phang, James M.
    CANCER RESEARCH, 2009, 69
  • [23] PRLZ INCREASES PROSTATE CANCER DOCETAXEL RESISTANCE BY INHIBITING LKB1/AMPK-MEDIATED AUTOPHAGY
    Zeng, Jin
    Liu, Wei
    Fan, Yizeng
    He, Dalin
    Li, Lei
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1228 - E1229
  • [24] Antagonism of miR-429 ameliorates anoxia/reoxygenation injury in cardiomyocytes by enhancing MO25/LKB1/AMPK mediated autophagy
    Zhu, Qingqing
    Hu, Fangfang
    LIFE SCIENCES, 2019, 235
  • [25] Stropharia Rugosoannulata Polysaccharides Alleviated Hyperlipidemia Via Lkb1/Ampk Signaling Pathway in Hepatocytes
    Wang, Tianyu
    Xu, Xinle
    Guo, Zixuan
    Li, Weizhuo
    Hou, Jumin
    Yin, Liying
    CURRENT TOPICS IN NUTRACEUTICAL RESEARCH, 2024, 22 (02) : 806 - 817
  • [26] AMPK induces vascular smooth muscle cell senescence via LKB1 dependent pathway
    Sung, Jin Young
    Woo, Chang-Hoon
    Kang, Young Jin
    Lee, Kwang Youn
    Choi, Hyoung Chul
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (01) : 143 - 148
  • [27] Vanadium(IV)-chlorodipicolinate alleviates hepatic lipid accumulation by inducing autophagy via the LKB1/AMPK signaling pathway in vitro and in vivo
    Huang, Ying
    Liu, Fang
    Zhang, Fang
    Liu, Pingsheng
    Xu, Tao
    Ding, Wenjun
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2018, 183 : 66 - 76
  • [28] DOWNREGULATION OF LEUKOCYTE LKB1/AMPK SIGNALING IS ASSOCIATED WITH THE SEVERITY OF GUILLAIN-BARRE SYNDROME INDEPENDENTLY OF AUTOPHAGY
    Paunovic, Verica
    Peric, Stojan
    Vukovic, Irena
    Stamenkovic, Marina
    Milosevic, Emina
    Stevanovic, Danijela
    Basta, Ivana
    Berisavac, Ivana
    Zdraljevic, Mirjana
    Bozovic, Ivo
    Stevic, Zorica
    Trajkovic, Vladimir
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S18 - S18
  • [29] MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling
    Ping Jin
    Jingwen Jiang
    Na Xie
    Li Zhou
    Zhao Huang
    Lu Zhang
    Siyuan Qin
    Shuyue Fu
    Liyuan Peng
    Wei Gao
    Bowen Li
    Yunlong Lei
    Edouard C. Nice
    Changlong Li
    Jichun Shao
    Ke Xie
    Cell Death & Disease, 10
  • [30] MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling
    Jin, Ping
    Jiang, Jingwen
    Xie, Na
    Zhou, Li
    Huang, Zhao
    Zhang, Lu
    Qin, Siyuan
    Fu, Shuyue
    Peng, Liyuan
    Gao, Wei
    Li, Bowen
    Lei, Yunlong
    Nice, Edouard C.
    Li, Changlong
    Shao, Jichun
    Xie, Ke
    CELL DEATH & DISEASE, 2019, 10 (8)